Document is current
Any future updates will be listed below
-
Authors
Tejero, Eudald
de Haro, María José Ramírez
Pujol, Roser
Bogliolo, Massimo https://orcid.org/0000-0001-8240-7784
Rodríguez-Santiago, Benjamín
Surrallés, Jordi https://orcid.org/0000-0002-4041-7519
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (FPU17/04141, PID2021–122411OB-I00/AEI/10.13039/501100011033/FEDER, PDC2022–133233-I00/AEI/10.13039/501100011033/Unión Europea Next Generation EU/PRTR, RED2022-134164-T)
Direcció General de Recerca, Generalitat de Catalunya (PI-G7180 HSP)
Instituto de Salud Carlos III (ICI22/00076, IMPaCT Genómica- Ref. IMP/00009, IMPaCT VUSCAN- Ref. PMP22/00064)
Institució Catalana de Recerca i Estudis Avançats (ICREA-Acadèmia program)
Agència de Gestió d'Ajuts Universitaris i de Recerca (2021-SGR-00835, 2023–2025)
Centro de Investigación Biomédica en Red en Enfermedades Raras
Fanconi Anemia Research Fund
Fundació la Marató de TV3 (ref. 202040-33)
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 16 July 2025
First Online: 14 October 2025
Declarations
:
: All relevant ethical regulations were applied and informed consent was obtained from all participants. This research has been performed in accordance with the Declaration of Helsinki.
: J.S. has signed agreements in the last 3 years (advisory boards, service provision, research collaboration, or material transfer) with Boehringer Ingelheim, Glaxo Smith Kline, Moderna Therapeutics, Roche, Rocket Pharmaceuticals and Pfizer.All the other authors declare that they have no conflict of interest.
